AA Axelrad
Impact in
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Physiology 10
- Erythrocyte Function and Pathophysiology 10
-
- Platelet Disorders and Treatments 5
- Erythropoietin and Anemia Treatment 2
- Co-authors
- D Eskinazi (5 shared papers)MM Shreeve (4 shared papers)T Grünberger (3 shared papers)Paulo N. Correa (3 shared papers)MH Freedman (2 shared papers)Andrew Cohen (2 shared papers)H Croizat (1 shared paper)Dominick Amato (1 shared paper)
- Journals
- Blood (15 papers)PubMed (3 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
AA Axelrad
18 papers receiving 617 citations
Peers
Comparison fields: 5 of 54
- Genetics 338
- Hematology 359
- Physiology 166
- Rheumatology 67
- Immunology 59
Countries citing papers authored by AA Axelrad
This map shows the geographic impact of AA Axelrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AA Axelrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AA Axelrad more than expected).
Fields of papers citing papers by AA Axelrad
This network shows the impact of papers produced by AA Axelrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AA Axelrad. The network helps show where AA Axelrad may publish in the future.
Co-authors
The 16 scholars most cited alongside AA Axelrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 156 | |
| 2 | 1976 | 120 | |
| 3 | 1991 | 71 | |
| 4 | 1995 | 61 | |
| 5 | 1991 | 56 | |
| 6 | 1993 | 45 | |
| 7 | 1980 | 43 | |
| 8 | 1983 | 37 | |
| 9 | Some hemopoietic negative regulators. | 1990 | 36 |
| 10 | 1976 | 10 | |
| 11 | 1991 | 9 | |
| 12 | 1995 | 6 | |
| 13 | 1983 | 4 | |
| 14 | 1980 | 3 | |
| 15 | 1994 | 3 | |
| 16 | The proliferative state of early erythropoietic progenitor cells (BFU-E) in human umbilical cord blood: low probability of finding BFU-E in DNA synthesis. | 1984 | 3 |
| 17 | 1993 | 1 | |
| 18 | A protein (NRP) that negatively regulates erythroid stem cell proliferation: antagonism to IL-3 stimulation. | 1990 | 1 |
About AA Axelrad
AA Axelrad is a scholar working on Physiology, Hematology, Genetics, Pulmonary and Respiratory Medicine and Rheumatology, having authored 18 papers that have together received 665 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (10 papers), Blood properties and coagulation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (5 papers), Eosinophilic Disorders and Syndromes (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Genetics (338 citations), Hematology (359 citations), Physiology (166 citations), Rheumatology (67 citations) and Immunology (59 citations). AA Axelrad has collaborated with scholars based in Canada, United States and China. Frequent co-authors include D Eskinazi, MM Shreeve, T Grünberger, Paulo N. Correa, MH Freedman, Andrew Cohen, H Croizat, Dominick Amato, A Bernstein and Jia Q. Ng. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.